A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions

8.8K views

⸱

DOI:

10.3791/56003

⸱

November 27th, 2017

 ,  ,  ,  ,  ,  , 

In This Article

Summary

This protocol describes the reprogramming of primary amniotic fluid and membrane mesenchymal stem cells into induced pluripotent stem cells using a non-integrating episomal approach in fully chemically defined conditions. Procedures of extraction, culture, reprogramming, and characterization of the resulting induced pluripotent stem cells by stringent methods are detailed.

Abstract

Autologous cell-based therapies got a step closer to reality with the introduction of induced pluripotent stem cells. Fetal stem cells, such as amniotic fluid and membrane mesenchymal stem cells, represent a unique type of undifferentiated cells with promise in tissue engineering and for reprogramming into iPSC for future pediatric interventions and stem cell banking. The protocol presented here describes an optimized procedure for extracting and culturing primary amniotic fluid and membrane mesenchymal stem cells and generating episomal induced pluripotent stem cells from these cells in fully chemically defined culture conditions utilizing human recombinant vitronectin and the E8 medium. Characterization of the new lines by applying stringent methods – flow cytometry, confocal imaging, teratoma formation and transcriptional profiling – is also described. The newly generated lines express markers of embryonic stem cells – Oct3/4A, Nanog, Sox2, TRA-1-60, TRA-1-81, SSEA-4 – while being negative for the SSEA-1 marker. The stem cell lines form teratomas in scid-beige mice in 6-8 weeks and the teratomas contain tissues representative of all three germ layers. Transcriptional profiling of the lines by submitting global expression microarray data to a bioinformatic pluripotency assessment algorithm deemed all lines pluripotent and therefore, this approach is an attractive alternative to animal testing. The new iPSC lines can readily be used in downstream experiments involving the optimization of differentiation and tissue engineering.

Introduction

The technology of induced pluripotent stem cells (iPSC) brings about potential cell replacement therapies, disease and developmental modeling, and drug and toxicological screening1,2,3. Replacement therapies can conceptually be achieved by cell injection, in-vitro differentiated tissue (such as cardiac patches) implantation, or guided regeneration by means of tissue engineering. Amniotic fluid (AFSC) and membrane stem cells (AMSC) are an excellent source of cells for these interventions either directly4,5,<....

Access restricted. Please log in or start a trial to view this content.

Protocol

The protocol follows institutional guidelines of the ethics committee for human research. Written consent of the patient was obtained for using the amniotic fluid for research.

This protocol follows the policies of the Institutional Animal Care and Use Committee of the University of South Alabama.

1. Isolation and Culture of Primary Amniotic Mesenchymal Stem Cells

  1. Plating of amniotic fluid cells
    1. Obtain a minimum of 2.5 mL of amniotic fluid harvested in the process of amniocentesis by a physician.
      NOTE: All handling of live cells and tissue must be performed in a st....

Access restricted. Please log in or start a trial to view this content.

Results

Informed written consent was obtained from patients before harvesting amniotic fluid for genetic testing purposes and dedicating a small aliquot of the fluid for research. No consent is required for the use of the amniotic membrane in research as the placenta represents medical waste. Amniotic fluid and membrane stem cells display typical mesenchymal properties, morphologically their cells are spindle-shaped and phase-bright. Upon reprogramming, the cells undergo mesenchymal-to-epithelial.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The initial phase of iPSC generation from fetal stem cells entails the extraction of the source cells from the fetal tissues, their culture, expansion, and introduction of the episomal reprogramming plasmids. This phase is followed by a culture period of around 14-18 days before the first fully reprogrammed colonies can be expanded. The final phase is maturation of the iPSC clones. The initial extraction of amniotic membrane stem cells is achieved by means of a combined mechanical and enzymatic digestion of the amnion. W.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare that they have no competing financial interests.

Acknowledgements

This work was supported by the Fonds Medizinische Forschung at the University of Zurich, Forschungskredit of the University of Zurich, The SCIEX NMSCh under Fellowships 10.216 and 12.176, The Swiss Society of Cardiology, The Swiss National Science Foundation under Grant [320030-122273] and [310030-143992], The 7th Framework Programme, Life Valve, European Commission under Grant [242008], the Olga Mayenfisch Foundation, the EMDO Foundation, the Start-up Grant 2012 of the University Hospital Zurich, and internal funding of the Mitchell Cancer Institute.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Tumor Dissociation Kit, humanMiltenyi Biotec130-095-929tissue dissociation system, reagent kit, includes tissue dissociation tubes and tissue dissociation enzymes
gentleMACS DissociatorMiltenyi Biotec130-093-235tissue dissociation system, dissociator
Thermo Scientific™ Shandon™ Disposable Scalpel No. 10, Sterile, Individually Wrapped, 5.75 (14.6cm)Thermo-Fisher3120032
70 µm cell strainersCorning10054-456
RPMI 1640 mediumThermo-Fisher32404014 
rocking platformVWR40000-300
50 ml centrifuge tubesThermo-Fisher339652
15 ml centrifuge tubesThermo-Fisher339650
EBM-2 basal mediumLonzaCC-3156basal medium for AFMC medium
FGF 2 Human (expressed in E. coli, non-glycosylated)Prospec BioCYT-218bFGF, supplement for AFMC medium
EGF Human, PichiaProspec BioCYT-332 EGF, supplement for AFMC medium
LR3 Insulin Like Growth Factor-1 Human RecombinantProspec BioCYT-022IGF, supplement for AFMC medium
Fetal Bovine Serum, embryonic stem cell-qualifiedThermo-Fisher10439024FBS
Antibiotic-Antimycotic (100X)Thermo-Fisher15240062 for primary AFSC/AMSC, for routine AFSC/AMSC it should not be necessary, do not use in medium for transfected cells!
Accutase cell detachment solutionStemCell Technologies07920cell detachment enzyme
CryoStor™ CS10StemCell Technologies07930complete freezing medium
PBS, pH 7.4Thermo-Fisher Scientific10010023 
EndoFree Plasmid Maxi Kit (10)Qiagen12362for plasmid isolation
pEP4 E02S EN2KAddgene20925EN2K, reprogramming factors Oct4+Sox2, Nanog+Klf4
pEP4 E02S ET2KAddgene20927ET2K, reprogramming factors Oct4+Sox2, SV40LT+Klf4
pCEP4-M2LAddgene20926M2L, reprogramming factors c-Myc+LIN28
NanoDrop 2000c UV-Vis SpectrophotometerThermo-FisherND-2000Cspectrophotometer
Neon® Transfection SystemThermo-FisherMPK5000transfection system, components:
Neon pipette - transfection pipette
Neon device - transfection device
Neon® Transfection System 10 µL KitThermo-FisherMPK1025consumables kit for the Neon Transfection System, it contains:
Neon tip - transfection tip
Neon tube - transfection tube
buffer R - resuspension buffer
buffer E - electrolytic buffer
Stemolecule™ Sodium ButyrateStemGent04-0005small molecule enhancer of reprogramming
TeSR-E8StemCell Technologies05940E8 medium
Vitronectin XF™StemCell Technologies07180VTN, stock concentration 250 µg/ml, used for coating at 1 µg/cm2 in vitronectin dilution (CellAdhere) buffer
CellAdhere™ Dilution BufferStemCell Technologies07183vitronectin dilution buffer
UltraPure™ 0.5M EDTA, pH 8.0Thermo-Fisher15575020dilute with PBS to 0.5 mM before use
EVOS® FL Imaging SystemThermo-Fisher ScientificAMF4300LCD imaging microscope system
CKX53 Inverted MicroscopeOlympusphase contrast cell culture microscope
Pierce™ 16% Formaldehyde (w/v), Methanol-freeThermo-Fisher28908dilute to 4% with PBS before use, diluted can be stored at 2-8 °C for 1 week
Perm Buffer IIIBD Biosciences558050permeabilization buffer, chill to -20 °C before use
Mouse IgG1, κ Isotype Control, Alexa Fluor® 488BD Biosciences557782isotype control for Oct3/4A, Nanog
Mouse IgG1, κ Isotype Control, Alexa Fluor® 647BD Biosciences557783isotype control for Sox2
Mouse anti-human Oct3/4 (Human Isoform A), Alexa Fluor® 488BD Biosciences561628
Mouse anti-human Nanog, Alexa Fluor® 488BD Biosciences560791
Mouse anti-human Sox-2, Alexa Fluor® 647BD Biosciences562139
Mouse IgGM, κ Isotype Control, Alexa Fluor® 488BD Biosciences401617isotype control for TRA-1-60
Mouse IgGM, κ Isotype Control, Alexa Fluor® 647BD Biosciences401618isotype control for TRA-1-81
Mouse anti-human TRA-1-60, Alexa Fluor® 488BD Biosciences330613
Mouse anti-human TRA-1-81, Alexa Fluor® 647BD Biosciences330705
Mouse IgG1, κ Isotype Control, Alexa Fluor® 488BD Biosciences400129isotype control for SSEA-1
Mouse IgG3, κ Isotype Control, Alexa Fluor® 647BD Biosciences401321isotype control for SSEA-4
Mouse anti-human SSEA-1, Alexa Fluor® 488BD Biosciences323010
Mouse anti-human SSEA-4, Alexa Fluor® 647BD Biosciences330407
Affinipure F(ab')2 Fragment Goat Anti-Mouse IgG+IgM, Alexa Fluor® 488Jackson Immunoresearch115-606-068use at a dilution of 1:600 or further optimize
Affinipure F(ab')2 Fragment Goat Anti-Mouse IgG+IgM, Alexa Fluor® 647Jackson Immunoresearch115-546-068use at a dilution of 1:600 or further optimize
DAPIThermo-Fisher ScientificD21490stock solution 10 mM, further dilute to 1:12.000 for a working solution
Corning® Matrigel® Growth Factor Reduced, Phenol Red-FreeCorning356231basement membrane matrix (BMM)
scid-beige mice, femaleTaconicCBSCBG-F
RNeasy Plus Mini Kit (50)Qiagen74134RNA isolation kit
T-25 flasks, tissue culture-treatedThermo-Fisher156367
T-75 flasks, tissue culture-treatedThermo-Fisher156499
Nunc™ tissue-culture dishThermo-Fisher12-567-650 10 cm tissue culture dish
6-well plates, tissue-culture treatedThermo-Fisher140675
Neubauer counting chamber (hemacytometer)VWR15170-173
Mr. Frosty™ Freezing ContainerThermo-Fisher5100-0001 freezing container
FACS tubes, Round Bottom Polystyrene Test Tube, 5mlCorning3520585 ml polystyrene tubes
Eppendorf tubes, 1.5 mlThermo-Fisher05-402-961.5 ml microcentrifuge tubes
PCR tubes, 200 µlThermo-Fisher14-222-262
pipette tips, 100 to 1250 µlThermo-Fisher02-707-407narrow-bore 1 mL tips
pipette tips, 5 to 300 µlThermo-Fisher02-707-410
pipette tips, 0.1 to 10 µlThermo-Fisher02-707-437
wide-bore pipette tips, 1000 µlVWR89049-166wide-bore 1 mL tips
glass Pasteur pipettesThermo-Fisher13-678-20A
ethanol, 200 proofThermo-Fisher04-355-451
vortex mixerVWR10153-842
chambered coverglass, 8-well, 1.5mm borosilicate glassThermo-Fisher155409glass-bottom confocal-grade cultureware
22G needlesVWR82002-366
insulin syringesThermo-Fisher22-253-260
Formalin solution, neutral buffered, 10%Sigma-AldrichHT501128-4Lfixation of explanted teratomas
Illumina HT-12 v4 Expression BeachChipIlluminaBD-103-0204expression microarray, supported by PluriTest, discontinued by manufacturer
PrimeView Human Genome U219 Array PlateThermo-Fisher901605expression microarray (formerly Affymetrix brand), soon to be supported by PluriTest
GeneChip™ Human Genome U133 Plus 2.0 ArrayThermo-Fisher902482expression microarray (formerly Affymetrix brand), supported by CellNet, soon to be supported by PluriTest
PluriTest®Coriell Institutewww.pluritest.org, free service for bioinformatic assessment of pluripotency, accepts microarray data - *.idat files from HT-12 v4 platform, soon to support U133, U219 microarray and RNA sequencing data
CellNetJohns Hopkins Universitycellnet.hms.harvard.edu, free service for bioinformatic identification of cell type, including plutipotent stem cells, based on U133 microarray data - *.cel files, soon to support RNA sequencing data

References

  1. Takahashi, K., Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 126 (4), 663-676 (2006).
  2. Yu, J., et al. Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cell....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Amniotic Fluid CellsMembrane Mesenchymal Stem CellsEpisomal ReprogrammingChemically Defined ConditionsHuman Recombinant VitronectinE8 MediumFlow CytometryConfocal ImagingTeratoma FormationTranscriptional Profiling